ArticleFrontiers in neuroscience2022
Prognostic Analysis for Patients With Parathyroid Carcinoma: A Population-Based Study.
Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 13 citations in OpenAlex.
- Prognostic factors and survival in parathyroid carcinoma: a 50-year single-center cohort study.Archives of endocrinology and metabolism · 2026Article
- The Impact of Adjuvant Radiotherapy Administration on Disease-Specific Survival in Patients with Parathyroid Carcinoma.Annals of surgical oncology · 2026Article
- Risk Factors of Distant Metastatic Parathyroid Carcinoma and Insights into Therapeutic Perspectives.Annals of surgical oncology · 2024Observational
- The prognostic value of lymph node dissection in patients with parathyroid carcinoma.Gland surgery · 2024Article
- Evaluation of factors predicting postoperative recurrence and metastasis of parathyroid cancer: a single-center study.World journal of surgical oncology · 2023Article
- Comparison of prognosis after partial and total surgical resection for parathyroid carcinoma: an inverse probability of treatment weighting analysis of the SEER database.Frontiers in endocrinology · 2023Article
- Article
- Mediastinal Parathyroid Cancer.Cancers · 2022Article
- Article
- Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.Frontiers in endocrinology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParathyroid carcinoma (PC) is a rare but often lethal malignancy for which staging system, prognostic indicators, and treatment guidelines are still not established. We aimed to explore the prognostic parameters and construct a nomogram for cancer-specific survival (CSS) of PC.
methodsA retrospective analysis of 604 PC patients in the SEER database from 2001 through 2018 was performed. All the cases were randomly assigned to the training cohort (
resultsAge at diagnosis > 70 years [hazard ratio (HR): 3.55, 95% CI: 1.07-11.78,
conclusionAge at diagnosis > 70 years, tumor size > 35 mm, and distant metastasis were independent risk factors for PC-specific mortality. Parathyroidectomy was currently the most recommended treatment for PC. This nomogram provided individualized assessment and reliable prognostic prediction for patients with PC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.